BETA: Please send your feedback!

Novartis

NOVN-CH:SWX

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

About

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
 website

Headquarters

Lichtstrasse 35
Basel, Basel-Stadt (Basle Town) 4056
41.61.324.11.11

Executives

Name Title Gender
Joseph Jimenez, Jr., MBA Chief Executive Officer Male
Hans Jšrg Reinhardt, PhD Independent Non-Executive Chairman Male
Felix R. Ehrat, PhD, LLD Group General Counsel Male
Steven Baert, MBA Head-Human Resources Male
Samir Shah, MD Global Head-Investor Relations Male
Harry Kirsch Chief Financial Officer Male
Vasant Narasimhan, MD Chief Medical Officer & Head-Drug Development Male

Mindful Investing Summary

  • Carbon Footprint
    1 N/A
  • Pollution Prevention
    4 N/A
  • Water Conservation
    4 N/A
  • Data & Privacy Protection
    — N/A
  • Consumer Health, Wellness & Safety
    2 N/A
  • Employee Ownership, Satisfaction, Benefits & Pay
    1 N/A
  • Workplace Health and Safety
    5 N/A
  • Integrity of Corporate Governance
    5 N/A
  • Ethical Practices
    1 N/A
  • Usage of Conflict Materials
    — N/A
  • Forced Labor
    — N/A
  • Diversity of Corporate Leadership
    3 N/A

Novartis - Competitors and Related Companies

How Novartis stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.

Novartis

NOVN-CH:SWX

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • 1
  • 4
  • 4
  • —
  • 2
  • 1
  • 5
  • 5
  • 1
  • —
  • —
  • 3
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Abbott Laboratories

ABT:NYS

Medical Specialties

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

AstraZeneca

AZN-GB:LON

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Bristol-Myers Squibb

BMY:NYS

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Merck

MRK:NYS

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Roche

ROG-CH:SWX

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership